Network pharmacology analysis identified key signalling pathways, including the PI3K-Akt, chemokine, cAMP, and MAPK signalling pathways, which are closely associated with chemerin and may contribute to the therapeutic effects of bile acids in the treatment of PCOS. This evidence concerns the gene PIK3CA and polycystic ovary syndrome.